Itch: Epidemiology, clinical presentation, and diagnostic workup
- PMID: 34428534
- PMCID: PMC8678917
- DOI: 10.1016/j.jaad.2021.07.076
Itch: Epidemiology, clinical presentation, and diagnostic workup
Abstract
Itch, or pruritus, is the uncomfortable sensation underlying the desire to scratch. Itch is a very common complaint in the general population that can result from dermatologic, systemic (eg, renal, hepatobiliary, endocrine), paraneoplastic, neuropathic, and psychogenic etiologies. Chronic itch is associated with significant sleep disturbances and profoundly reduces overall quality of life. Certain populations, including elderly and African Americans, are at increased risk of experiencing heightened burden of itch. Because of the variable clinical presentation and wide-ranging etiologies, itch presents a challenge for clinicians. The initial evaluation should include a complete blood count, with differential, hepatic, renal, and thyroid function testing along with diabetes screening. Further testing should be guided by history and physical examination findings. There should be a heightened concern for underlying malignancy in individuals older than 60 years of age who have a history of liver disease and diffuse itch less than 12 months of duration. For individuals with chronic pruritus of unknown origin, increased blood eosinophils may serve as a biomarker of T helper cell type 2 polarization and response to immunomodulator therapies. In this first part of a 2-part continuing medical education series, we describe the broader epidemiology and specific conditions associated with itch and the clinical presentation and diagnostic workup for patients with itch.
Keywords: clinical features; diagnostic workup; epidemiology; itch; pruritus.
Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest Dr Kwatra is an advisory board member or consultant for AbbVie, Celldex Therapeutics, Incyte Corporation, Galderma, Pfizer Inc, Regeneron Pharmaceuticals, and Menlo Therapeutics; is an investigator or has received grant funding from GaldermaSA, Kiniksa Pharmaceuticals, Pfizer Inc, and Sanofi; is a recipient of a Dermatology Foundation Medical Dermatology Career Development Award and has received grant funding from the Skin of Color Society; and is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under the award number K23AR077073. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Authors Roh, Choi, and Sutaria have no conflicts of interest to declare.
Figures
Similar articles
-
Approach to the Patient with Chronic Pruritus.Med Clin North Am. 2021 Jul;105(4):699-721. doi: 10.1016/j.mcna.2021.04.007. Med Clin North Am. 2021. PMID: 34059246 Review.
-
Aetiology, pathogenesis and management of neuropathic itch: A narrative review with recent updates.Indian J Dermatol Venereol Leprol. 2023 [SEASON];90(1):5-18. doi: 10.25259/IJDVL_846_2022. Indian J Dermatol Venereol Leprol. 2023. PMID: 37317726 Review.
-
Chronic eyelid and ocular itch.Clin Dermatol. 2023 Jul-Aug;41(4):509-514. doi: 10.1016/j.clindermatol.2023.08.004. Epub 2023 Aug 11. Clin Dermatol. 2023. PMID: 37574153
-
Unmet needs in treating itch: reaching beyond eczema.J Dermatolog Treat. 2024 Jun 13;35(1):2351487. doi: 10.1080/09546634.2024.2351487. Epub 2024 Jun 30. J Dermatolog Treat. 2024. PMID: 38945542 Review.
-
Causes, pathophysiology, and treatment of pruritus in the mature patient.Clin Dermatol. 2018 Mar-Apr;36(2):140-151. doi: 10.1016/j.clindermatol.2017.10.005. Epub 2017 Oct 17. Clin Dermatol. 2018. PMID: 29566918
Cited by
-
Effectiveness of anti-psychiatric treatment on visual and haptic perceptual disorder for a patient with Alzheimer's disease: A case report.World J Psychiatry. 2024 Sep 19;14(9):1404-1410. doi: 10.5498/wjp.v14.i9.1404. eCollection 2024 Sep 19. World J Psychiatry. 2024. PMID: 39319233 Free PMC article.
-
Symptom clusters and network analysis of patients with intermediate and advanced liver cancer treated with targeted immunotherapy.Support Care Cancer. 2024 Aug 8;32(9):580. doi: 10.1007/s00520-024-08784-w. Support Care Cancer. 2024. PMID: 39115725
-
Plasma metabolomic profiling reveals a novel circulating biomarker signature in chronic pruritus of unknown origin.Sci Rep. 2024 Jul 29;14(1):17472. doi: 10.1038/s41598-024-67170-y. Sci Rep. 2024. PMID: 39080299 Free PMC article.
-
The effect of photobiomodulation on histamine and Mucuna pruriens-induced pruritus, hyperknesis and alloknesis in healthy volunteers: A double-blind, randomized, sham-controlled study.PLoS One. 2024 Jul 18;19(7):e0307034. doi: 10.1371/journal.pone.0307034. eCollection 2024. PLoS One. 2024. PMID: 39024251 Free PMC article. Clinical Trial.
-
Short-term Heat Application Reduces Itch Intensity in Atopic Dermatitis: Insights from Mechanical Induction and Real-life Episodes.Acta Derm Venereol. 2024 Jun 17;104:adv40127. doi: 10.2340/actadv.v104.40127. Acta Derm Venereol. 2024. PMID: 38887031 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
